Enhancing hepatitis C testing and treatment among people who inject drugs

Back to search results
PROJECT DESCRIPTION

The PhD candidate will be trained to conduct novel, high-quality research integrating social research and epidemiology across NHMRC-funded KI-CSRH studies to improve HCV testing, treatment, and post-treatment care among marginalised populations. The candidate will be responsible for social and epidemiological research from a cohort study evaluating HCV treatment in drug-treatment clinics (ETHOS), a cluster-randomized trial of point-of-care HCV testing to enhance treatment in needle/syringe programmes (TEMPO, funded by SPHERE/Triple-I), and a cohort study of HCV reinfection following treatment (SHARP). These projects are linked to an NHMRC-funded Centre for Research Excellence on Point-of-Care Testing (CIs Grebely/Treloar) offering further training opportunities.

IDEAL CANDIDATE

The PhD candidate will be highly self-motivated and organised with an exceptional ability to critically analyse, synthesise, and present research findings. Since the PhD candidate will undertake interdisciplinary training at KI and CSRH, the candidate must have a Bachelor’s degree (with Hons) or preferably, a Master’s degree in either Medicine or Social Sciences. The candidate should have evidence of high-quality academic outputs, notably, publications in peer-reviewed journals, and other research-related experience (e.g. conference presentations). The candidate should have familiarity with STATA or SASS. Experience in conducting mixed-methods research (qualitative and quantitative) is desirable. More importantly, the candidate must demonstrate a high willingness to engage in both types of research methodologies, as needed, and respond well to supervision feedback.
Supervisory team
Carla
Treloar

Arts & Social Sciences
Other
Alison
Marshall

Medicine
The Kirby Institute
Jason
Grebely

Medicine
The Kirby Institute
amarshall@kirby.unsw.edu.au